Admin Panel

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

Source: Business Wire | Published: 2026-02-23T13:03:00+00:00

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

ClearNote Health updated its Avantect pancreatic cancer test, reporting industry-leading early detection sensitivity and specificity.

Why it mattersAvantect's improved pancreatic cancer sensitivity and specificity should prompt clinical teams to pilot outpatient screening.

Read Original Source

Back to Longevity News